Integral Diagnostics Limited (ASX:IDX)
Australia flag Australia · Delayed Price · Currency is AUD
2.330
0.00 (0.00%)
Aug 27, 2026, 4:10 PM AEST

Integral Diagnostics Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Integral Diagnostics stock has a consensus rating of "Buy" and an average price target of $3.01. The average 1-year stock price forecast is 29.18% higher than the current stock price, while the lowest is $2.24 (-3.86%) and the highest is $3.70 (+58.80%).

Price Target: $3.01 (+29.18%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.24$3.01$3.18$3.70
Change-3.86%+29.18%+36.48%+58.80%

Analyst Ratings

The average analyst rating for Integral Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy988889
Buy333444
Hold001111
Sell000000
Strong Sell110000
Total131212131314

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jarden
Jarden
Buy
Maintains
$2.95
BuyMaintains$2.95+26.61%Aug 27, 2026
Jefferies
Jefferies
Buy
Maintains
$3.50$3.30
BuyMaintains$3.50$3.30+41.63%Aug 27, 2026
Bell Potter
Bell Potter
Buy
Maintains
$3.60$3.15
BuyMaintains$3.60$3.15+35.19%Aug 26, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$3.50
BuyMaintains$3.50+50.21%Aug 26, 2026
Ord Minnett
Ord Minnett
Buy
Maintains
$3.20$3.30
BuyMaintains$3.20$3.30+41.63%Aug 26, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
837.72M
from 788.62M
Increased by 6.23%
Revenue Next Year
888.84M
from 837.72M
Increased by 6.10%
EPS This Year
0.13
from 0.13
Increased by 6.32%
EPS Next Year
0.16
from 0.13
Increased by 17.97%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
360.93M440.76M469.70M627.22M788.62M837.72M
Revenue Growth
2.92%22.12%6.57%33.54%25.73%6.23%
Gross Profit
122.10M142.43M151.90M195.98M243.36M284.83M
Gross Margin
33.83%32.31%32.34%31.25%30.86%34.00%
Operating Income
38.62M38.47M42.17M56.80M73.84M101.07M
Net Income
14.60M25.04M-60.70M2.69M21.93M44.12M
EPS
----0.130.13
EPS Growth
----23.53%6.32%
Forward PE
17.4225.9927.6720.3213.7717.39
Dividend / Share
0.070.060.060.070.090.09
Dividend Growth
-44.00%-14.29%-3.33%12.07%43.08%-0.33%
Free Cash Flow
16.84M20.14M37.44M60.91M53.54M62.74M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202720282029
High846.0M
Avg837.7M
Low833.8M

Revenue Growth

Revenue Growth202720282029
High
7.3%
Avg
6.2%
Low
5.7%

EPS Forecast

EPS202720282029
High0.14
Avg0.13
Low0.13

EPS Growth

EPS Growth202720282029
High
11.9%
Avg
6.3%
Low
1.4%